Avalo: Edison Open House Healthcare 2022

Avalo: Edison Open House Healthcare 2022

Avalo Therapeutics — 1 video in collection

More on this equity

Avalo is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical need in the areas of immunology, immuno-oncology and rare disease.

• Tell us about the company.
• How many programmes are you running at the moment?
• Which programmes should investors be focusing on?
• What is the unmet medical need in Crohn’s disease and how is Avalo different in this market?
• How large do you think the Crohn’s market is?
• Tell us about the recent encouraging data on Crohn’s disease.
• Is there a possibility that some people could become refractory to your drug?
• Which milestones should investors focus on in the coming year?
• Please tell us more about your close association with the Children’s Hospital of Philadelphia.


You may also be interested in these:

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free